UNICHEMLABNSEUnichem Laboratories Limited· PharmaceuticalsLowNeutral
Announced Mon, 30 Jun · 21:14 IST

Ipca Laboratories Ltd has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

UNICHEMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ipca Laboratories Ltd, a promoter of Unichem Laboratories, has submitted a declaration under SEBI Regulation 31(4) for the financial year ended 31 March 2025. The declaration states that the promoters and persons acting in concert have not created any encumbrance — such as a pledge, lien, or charge — directly or indirectly on the equity shares they hold in Unichem Laboratories. This is an annual negative confirmation, meaning no new encumbrances were created during the year and the existing shareholding remains unencumbered. The filing is purely a compliance formality required by SEBI takeover regulations.

Likely market impact

This is a routine, neutral filing with no material impact on the stock price. Shareholders can be reassured that promoters have not pledged their Unichem shares, reducing concerns about forced selling or margin call risks.